Level B· Emerging clinical evidence with positive signalsClinical TrialEurope PMCOpen access

Evolving Strategies for Knee Osteoarthritis: A Narrative Review of Integrated Rehabilitation, Pharmacologic, and Joint-Preserving Interventions

Wang H., Cui L.

Clinical Trial on Knee Osteoarthritis, Osteoarthritis, published in Med Sci Monit (2026) — summary generated from the PubMed abstract.

Open my reading list
Level B· Emerging clinical evidence with positive signalsEvidence level of this study

Several human studies show positive signals, while research methods and sample sizes continue to develop.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Clinical Trial
Journal
Med Sci Monit (2026)
Reported sample size
—
Source database
Europe PMC
PMID
42169392
PMCID
PMC13203996
DOI
10.12659/msm.952864

Abstract (original English)

Knee osteoarthritis (KOA) is a primary driver of global disability, currently affecting over 365 million adults, with projections suggesting a 74.9% increase by 2050. Conventional clinical practice often prioritizes end-stage surgical outcomes while neglecting systematic, early-stage interventions designed to arrest disease progression. To ensure a robust synthesis of evidence, we conducted a systematic search of PubMed, Embase, and Web of Science (2020-2025) for high-quality clinical trials, meta-analyses, and guidelines. These selected sources were synthesized to identify the latest advancements in KOA management. This narrative review evaluates the clinical transition from reactive, surgery-centric models to a proactive, integrated framework to mitigate the profound socioeconomic burden and functional decline associated with the disease. We synthesized evidence across non-pharmacological rehabilitation, pharmacotherapy, and advanced joint-preserving surgeries, emphasizing optimal intervention windows and stage-specific mechanobiological requirements. Current "one-size-fits-all" approaches often fail to bridge the gap between initial conservative care and radical arthroplasty. Evidence indicates that while conservative treatments offer symptomatic relief, the strategic incorporation of joint-preserving surgeries - targeted at biomechanical realignment - is critical to bridge

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Several human studies show positive signals, while research methods and sample sizes continue to develop.

How we grade evidence
Knee JointHumansOsteoarthritis, Knee

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research